echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Nat Commun: What is the acceptance and effectiveness of the BNT162b2 vaccine by British medical staff?

    Nat Commun: What is the acceptance and effectiveness of the BNT162b2 vaccine by British medical staff?

    • Last Update: 2021-06-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The COVID-19 pandemic has already had a major impact on the population of the world
    .


    Among them, health care workers (HCWs) have been particularly affected, so they have been designated as a high priority group by the British Joint Committee on Vaccination and Immunization


    immunity

    The administration plan of the BNT162B2 vaccine is to inject a dose of 30 micrograms on day 0 and repeat the injection at least 21 days later.
    However, due to limited supply, the British government’s strategy is to postpone the second injection until 3 months later
    .

    Recently, in a single-center cohort study in London, researchers evaluated the absorption and effectiveness of a single-dose BNT162b2 vaccine by British healthcare workers (HCWs) during the high incidence of COVID-19 in the community
    .

    COVID-19

    The results showed that the early absorption rate of medical staff was 62.
    3% (1409/2260) , but the absorption rate of different age groups, races and different job roles was significantly different
    .


    After a vaccine working group implemented specific measures, the absorption rate rose to 72.


    The early absorption rate of medical staff was 62.


    The Kaplan-Meier curves of the partially vaccinated group and the unvaccinated group were consistent before the 14th day, and continued to diverge before the 42th day


    Kaplan-Meier estimates the time when vaccinated and unvaccinated health workers are first infected with COVID-19

    Kaplan-Meier estimates vaccinated and unvaccinated health workers first infected time COVID-19 of the Kaplan-Meier estimates of health workers vaccinated and unvaccinated first infection time of COVID-19 infection

    Cox regression analysis showed that the risk of contracting COVID-19 among some vaccinated high-risk groups was reduced by 70.


    Part of the vaccinated high-risk population has a 70.


    In the first-line clinical setting, the BNT162B2 vaccine is effective from 14 days after vaccination, and still has a protective effect within 21 days after the first injection, without the need for a second injection


    BNT162B2 vaccine is effective from 14 days after vaccination, and still has a protective effect within 21 days after the first shot.


    Original source:

    Original source:

    Tariq Azamgarhiet al.


    Tariq Azamgarhi et al.


     

     

    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.